Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
TolerogenixX´ MIC therapy receives EMA PRIME designation; up to 10-year follow‑up data support sustained safety and reduced immunosuppression
-
Eledon Pharmaceuticals Announces Orphan Drug Designation Granted to Tegoprubart for the Prevention of Allograft Rejection in Liver Transplantation
-
Eledon Pharmaceuticals to Participate in Leerink Partners 2026 Global Healthcare Conference
-
Anderson recognized among 50 women leaders transforming industries, honored for advancing organ preservation through innovation, global expansion, and a landmark acquisition Dr. Lisa Anderson named...
-
Eledon Pharmaceuticals to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
-
WALTHAM, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Paragonix Technologies, a pioneer in organ transplant technologies and services, today announced a donor kidney case in which the Paragonix...
-
Eledon Pharmaceuticals Presents Long-Term Phase 1b Data for Tegoprubart in Kidney Transplant Patients at ASTS
-
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2026 Outlook
-
WALTHAM, Mass., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Paragonix Technologies, a leader in advanced organ transplant preservation and organ procurement services, announced today that University Hospitals...
-
WALTHAM, Mass., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Paragonix Technologies, a pioneer in organ transplant technologies and services, announced today the publication of groundbreaking research on...